Nexbon Lifesciences
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg)
Glimnex MV 2mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults.
Tablet
Glimnex MV 2mg/500mg/0.2mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimnex MV 2mg/500mg/0.2mg Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimnex MV 2mg/500mg/0.2mg Tablet.
Glimnex MV 2mg/500mg/0.2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimnex MV 2mg/500mg/0.2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimnex MV 2mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimnex MV 2mg/500mg/0.2mg Tablet is a combination of three medications: Glimepiride, Metformin and Voglibose. This medicine is used to treat type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken alongside proper diet and regular exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas. Metformin reduces glucose production in the liver and enhances insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that decreases postprandial (after meals) blood glucose levels. This combination is not suitable for treating Type 1 DM.
Common side effects of Glimnex MV 2mg/500mg/0.2mg Tablet include hypoglycemia (low blood sugar level), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infections.
It is essential to avoid using this medicine in patients with known allergies to any of its components or excipients, and also individuals with moderate to severe kidney disease, inflammatory bowel disease (IBD), colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis.
No, consuming alcohol along with Glimnex MV 2mg/500mg/0.2mg Tablet is not advisable. It may lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Glimnex MV 2mg/500mg/0.2mg Tablet can lead to hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It is more likely to occur when you miss meals, drink alcohol, over-exercise, or take other antidiabetic medication along with it. Regular monitoring of your blood sugar levels is crucial. Always keep glucose tablets, honey, or fruit juice readily available.
Store this medication in its original container with the seal intact, in a cool, dry place. Follow the storage instructions provided on the package label. Dispose of unused medications according to local guidelines and ensure they are not accessible by pets, children, or other people.